Edition:
India

Livzon Pharmaceutical Group Inc (1513.HK)

1513.HK on Hong Kong Stock

65.00HKD
19 Jan 2018
Change (% chg)

HK$-1.30 (-1.96%)
Prev Close
HK$66.30
Open
HK$66.10
Day's High
HK$66.45
Day's Low
HK$64.30
Volume
695,941
Avg. Vol
530,971
52-wk High
HK$68.90
52-wk Low
HK$32.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 2,148.73 0.414
Mar '17 2,126.03 0.497
FY 2016 Dec '16 1,927.93 0.312
Sep '16 1,939.55 0.408
Jun '16 2,038.73 0.353
Mar '16 1,745.57 0.590
 
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 2,800.13 2,813.85 2,786.42 --
Quarter Ending Jun-18 2 2,891.45 2,939.00 2,843.90 --
Year Ending Dec-18 6 11,842.70 12,400.00 11,470.10 12,949.50
Earnings (per share)
Quarter Ending Mar-18 3 0.64 0.69 0.59 --
Quarter Ending Jun-18 3 0.61 0.66 0.53 --
Year Ending Dec-18 7 2.45 2.54 2.31 2.44
Sales and Profit Figures in Hong Kong Dollar (HKD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 23.38 31.10 32.90
P/E High - Last 5 Yrs. 21.72 40.98 46.03
P/E Low - Last 5 Yrs. 19.33 23.80 24.39
Beta 0.64 0.90 0.89
Price to Sales (TTM) 3.15 3.98 5.45
Price to Book (MRQ) 3.08 4.82 5.38
Price to Tangible Book (MRQ) 3.97 5.57 6.89
Price to Cash Flow (TTM) -- 23.02 23.43
% Owned Institutions -- 1.23 2.16

Dividends

  Company industry sector
Dividend Yield 0.98 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.35 5.23
Payout Ratio(TTM) 24.20 45.67 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 5.40 3.59 9.01
Sales (TTM) vs TTM 1 Yr. Ago 11.70 4.69 5.44
Sales - 5 Yr. Growth Rate 19.33 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago 17.38 16.23 19.33
EPS (TTM) vs TTM 1 Yr. Ago 8.92 -- --
EPS - 5 Yr. Growth Rate 15.99 9.86 10.77
Capital Spending - 5 Yr. Growth Rate 1.10 15.30 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.25 2.11 2.18
Current Ratio (MRQ) 1.38 2.88 2.97
LT Debt to Equity (MRQ) 0.01 9.81 12.10
Total Debt to Equity (MRQ) 10.87 13.80 16.38
Interest Coverage (TTM) 74.42 36.25 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 62.78 55.13 54.76
Gross Margin - 5 Yr. Avg. 62.03 52.41 52.45
EBITD Margin (TTM) 13.16 -- --
EBITD - 5 Yr. Avg 17.05 18.54 15.33
Operating Margin (TTM) 12.48 14.40 7.60
Operating Margin - 5 Yr. Avg. 11.49 14.46 10.79
Pre-Tax Margin (TTM) 14.12 14.82 8.38
Pre-Tax Margin - 5 Yr. Avg. 12.88 14.77 11.19
Net Profit Margin (TTM) 11.70 11.09 4.70
Net Profit Margin - 5 Yr. Avg. 10.72 11.11 7.50
Effective Tax Rate (TTM) 17.09 23.16 23.05
Effective Tax Rate - 5 Yr. Avg. 16.75 23.40 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,517,735 948,195,516 855,725,045
Net Income/Employee (TTM) 177,612 111,561,295 100,665,187
Receivable Turnover (TTM) 4.88 5.61 5.76
Inventory Turnover (TTM) 2.85 2.57 3.34
Asset Turnover (TTM) 0.67 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 7.88 11.41 10.97
Return on Assets - 5 Yr. Avg. 8.66 12.98 12.39
Return on Investment (TTM) 16.23 14.84 14.40
Return on Investment - 5 Yr. Avg. 14.82 16.97 16.20
Return on Equity (TTM) 15.26 16.32 16.09
Return on Equity - 5 Yr. Avg. 14.96 18.05 17.53
  1 Year 3 Year 5 Year
Sales % 15.58 18.33 19.33
EPS (TTM) % 21.85 15.82 15.99
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Livzon Pharmaceutical Group Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 17.14%
# of Holders: 53
Total Shares Held: 32,440,366
3 Mo. Net Change: -109,454
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 7
# Reduced Positions: 11
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.